Yun Zeng
Overview
Explore the profile of Yun Zeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
1414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wu K, Li Y, Nie B, Guo C, Ma X, Li L, et al.
Int J Oncol
. 2024 Sep;
65(5).
PMID: 39329212
Acute myeloid leukemia (AML) is a hematological malignancy with a high relapse rate and a poor survival rate. The circular RNA circPVT1 and myocyte enhancer factor 2A (MEF2A) have unique...
12.
Tang W, Li Y, Zhang L, Zhong X, Liang Q, Zheng Y, et al.
Cancer Med
. 2024 Jul;
13(14):e7435.
PMID: 39031941
Objective: TQB3602 is a novel orally bioavailable proteasome inhibitor. This study is the first-in-human phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of TQB3602 in...
13.
Jaddi S, Malik M, Wang B, Pugno N, Zeng Y, Coulombier M, et al.
Nat Commun
. 2024 Jul;
15(1):5863.
PMID: 38997272
Fail-safe design of devices requires robust integrity assessment procedures which are still absent for 2D materials, hence affecting transfer to applications. Here, a combined on-chip tension and cracking method, and...
14.
Chang P, Guo Y, Chen D, Li K, Wang W, Yang Z, et al.
J Nanobiotechnology
. 2024 Jun;
22(1):374.
PMID: 38926723
Background: Hypoxia-activated prodrugs present new opportunities for safe and effective tumor drug resistance therapy due to their high selectivity for hypoxic cells. However, the uneven distribution of oxygen in solid...
15.
Mei H, Liu X, Li Y, Zhou H, Feng Y, Gao G, et al.
Ann Hematol
. 2024 Jun;
103(7):2273-2281.
PMID: 38842566
While studies have explored the feasibility of switching between various thrombopoietin receptor agonists in treating immune thrombocytopenia (ITP), data on the switching from eltrombopag to hetrombopag remains scarce. This post-hoc...
16.
Zhang Q, Zeng Y, Zhao Y, Peng X, Ren E, Liu G
Bioengineering (Basel)
. 2024 Apr;
11(4).
PMID: 38671732
Magnetic robots possess an innate ability to navigate through hard-to-reach cavities in the human body, making them promising tools for diagnosing and treating diseases minimally invasively. Despite significant advances, the...
17.
Yu Z, Gao Z, Zeng Y, Li M, Xu G, Ren M, et al.
Front Mol Biosci
. 2024 Apr;
11:1361386.
PMID: 38665935
Coilia nasus is an anadromous fish that has been successfully domesticated in the last decade due to its high economic value. The fish exhibits a delayed ovary development during the...
18.
Wang X, Zhou Z, Wang Z, Xue Y, Zeng Y, Gao J, et al.
Nanoscale
. 2024 Apr;
16(18):9136.
PMID: 38661520
Expression of concern for 'Gadolinium embedded iron oxide nanoclusters as - dual-modal MRI-visible vectors for safe and efficient siRNA delivery' by Xiaoyong Wang , , 2013, , 8098-8104, https://doi.org/10.1039/C3NR02797J.
19.
An X, Zeng Y, Liu C, Liu G
Pharmaceutics
. 2024 Jan;
16(1).
PMID: 38258033
The medical community is constantly searching for new and innovative ways to treat cancer, and cellular-membrane-derived artificial vesicles are emerging as a promising avenue for cancer immunotherapy. These vesicles, which...
20.
Chen H, Wen Y, Zeng Y, Lin L, Sun B, Zhu H, et al.
Oncol Ther
. 2023 Dec;
12(1):131-145.
PMID: 38104036
Introduction: Chronic myeloid leukemia (CML) is a chronic disease with treatment-free remission (TFR) increasingly regarded as a feasible goal of treatment. However, various factors may influence adherence to international guidelines...